|
Name |
Bostrycoidin
|
Molecular Formula | C15H11NO5 | |
IUPAC Name* |
6,9-dihydroxy-7-methoxy-3-methylbenzo[g]isoquinoline-5,10-dione
|
|
SMILES |
CC1=CC2=C(C=N1)C(=O)C3=C(C2=O)C(=C(C=C3O)OC)O
|
|
InChI |
InChI=1S/C15H11NO5/c1-6-3-7-8(5-16-6)14(19)11-9(17)4-10(21-2)15(20)12(11)13(7)18/h3-5,17,20H,1-2H3
|
|
InChIKey |
FGNZMGUTILLWJB-UHFFFAOYSA-N
|
|
Synonyms |
Bostrycoidin; 4589-33-7; NSC103645; RNE518Z6ZA; NSC-103645; Benz[g]isoquinoline-5,10-dione, 6,9-dihydroxy-7-methoxy-3-methyl-; UNII-RNE518Z6ZA; Benz(g)isoquinoline-5,10-dione, 6,9-dihydroxy-7-methoxy-3-methyl-; NSC 103645; BOSTRYCOIDIN [MI]; SCHEMBL2137144; CHEMBL1999208; DTXSID70963456; 5,8-dihydroxy-6-methoxy-3-methyl-2-aza-9,10-anthraquinone; 6,9-dihydroxy-7-methoxy-3-methylbenzo[g]isoquinoline-5,10-dione; ZINC1680483; NCI60_000088; DS-006452; Q27288203; Benz[g]isoquinoline-5, 6,9-dihydroxy-7-methoxy-3-methyl-; 6,9-dihydroxy-7-methoxy-3-methyl-benzo[g]isoquinoline-5,10-dione; Benz[g]isoquinoline-5,10-dione,6,9-dihydroxy-7-methoxy-3-methyl-; 6,9-DIHYDROXY-7-METHOXY-3-METHYLBENZ(G)ISOQUINOLINE-5,10-DIONE
|
|
CAS | 4589-33-7 | |
PubChem CID | 72631 | |
ChEMBL ID | CHEMBL1999208 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 285.25 | ALogp: | 2.6 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 96.7 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.665 |
Caco-2 Permeability: | -4.84 | MDCK Permeability: | 0.00001730 |
Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.025 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.05 |
Blood-Brain-Barrier Penetration (BBB): | 0.017 | Plasma Protein Binding (PPB): | 95.82% |
Volume Distribution (VD): | 0.435 | Fu: | 4.73% |
CYP1A2-inhibitor: | 0.956 | CYP1A2-substrate: | 0.868 |
CYP2C19-inhibitor: | 0.08 | CYP2C19-substrate: | 0.116 |
CYP2C9-inhibitor: | 0.376 | CYP2C9-substrate: | 0.299 |
CYP2D6-inhibitor: | 0.562 | CYP2D6-substrate: | 0.29 |
CYP3A4-inhibitor: | 0.529 | CYP3A4-substrate: | 0.131 |
Clearance (CL): | 4.357 | Half-life (T1/2): | 0.309 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.825 |
Drug-inuced Liver Injury (DILI): | 0.965 | AMES Toxicity: | 0.861 |
Rat Oral Acute Toxicity: | 0.418 | Maximum Recommended Daily Dose: | 0.901 |
Skin Sensitization: | 0.85 | Carcinogencity: | 0.749 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.108 |
Respiratory Toxicity: | 0.859 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003447 | 0.781 | D06GCK | 0.313 | ||||
ENC002239 | 0.727 | D07MGA | 0.311 | ||||
ENC002089 | 0.647 | D01XWG | 0.290 | ||||
ENC003446 | 0.647 | D0N1FS | 0.287 | ||||
ENC005551 | 0.534 | D07VLY | 0.283 | ||||
ENC006089 | 0.534 | D0C9XJ | 0.283 | ||||
ENC000336 | 0.526 | D01XDL | 0.281 | ||||
ENC002766 | 0.526 | D0T8EH | 0.247 | ||||
ENC005490 | 0.526 | D0K8KX | 0.245 | ||||
ENC000939 | 0.520 | D06QKV | 0.244 |